EN
HI
Summary
As of 26 Aug, 2026, Aspira Pathlab & Diagnostics stock price is ₹86.5. During the trading session, the stock has moved between an intraday low of ₹86.50 and an intraday high of ₹86.50. Over the last 52 weeks, Aspira Pathlab & Diagnostics has traded between ₹49.00 and ₹135.88.
The stock has recorded a trading volume of 5,782 shares, with a market capitalization of ₹10293000. Its Average Traded Price (ATP) is ₹86.50, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 5698 @ ₹86.50.
Aspira Pathlab & Diagnostics has an upper circuit limit of ₹88.20 and a lower circuit limit of ₹84.80. The total value traded stands at ₹5.00 L, and the delivery percentage for the day is 100%.
The stock is currently traded with a market lot size of 1. Aspira Pathlab & Diagnostics also offers a dividend yield of 0%.
Aspira Pathlab & Diagnostics share price chart
Aspira Pathlab & Diagnostics Share Key Metrics
Volume
5782.00
Market Cap
89.03 CR
LTQ@LTP
5698@86.50
ATP
86.5
Var Margin
100 %
Circuit Range
84.8-88.2
Delivery %
100 %
Value
5.00 L
ASM/GSM
No
Market Lot
1
Aspira Pathlab & Diagnostics Fundamentals
P/E Ratio
37.11
P/B Ratio
7.05
Div. Yield
0
Sector P/E
48.3
Sector P/B
-14.2
Sec. Div. Yield
0.17
Aspira Pathlab & Diagnostics Resistance and Support
Pivot 86.5
Resistance
First Resistance
86.5
Second Resistance
86.5
Third Resistance
86.5
Support
First Support
86.5
Second Support
86.5
Third Support
86.5
Aspira Pathlab & Diagnostics Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Tue Aug 25 2026 | 86.5 | 86.5 | -1.98% | 86.5 | 86.5 |
| Mon Aug 24 2026 | 88.25 | 88.25 | -2.00% | 88.25 | 88.25 |
| Fri Aug 21 2026 | 90.05 | 90.05 | -1.95% | 90.05 | 90.05 |
Aspira Pathlab & Diagnostics Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-12 | Quarterly Results & Raising of funds |
| 2026-05-23 | Audited Results |
| 2026-02-10 | Quarterly Results |
| 2025-11-12 | Quarterly Results |
| 2025-08-12 | Quarterly Results |
| 2025-05-16 | Audited Results |
| 2025-02-07 | Quarterly Results |
| 2024-11-12 | Quarterly Results |
| 2024-08-13 | Quarterly Results |
Aspira Pathlab & Diagnostics News
Aspira Pathlab & Diagnostics Ltd - 540788 - Announcement under Regulation 30 (LODR)-Change in Management
Aspira Pathlab's Board re-designated Mr. Nikunj Velji Mange as Managing Director and appointed Mr. Vaibhav Odhekar as Additional Executive Director, both effective August 12, 2026. These appointments are subject to shareholder approval.
Aug 12 2026 16:51:21
Aspira Pathlab & Diagnostics Ltd - 540788 - Board Meeting Intimation for Approval Of Un-Audited Financial Result (Standalone) For The First Quarter Ended On June 30,2026 And To Transact Other Businesses
Aspira Pathlab & Diagnostics Ltd board will meet on August 12, 2026, to consider Q1 FY27 financial results. The agenda also includes a proposal for raising funds.
Aug 06 2026 15:30:20
Aspira Pathlab & Diagnostics Management
| Name | Position |
|---|---|
| Haseeb A Drabu | Chairman |
| Pankaj Shah | Managing Director & Chief Executive Officer |
Aspira Pathlab & Diagnostics Similar Stocks
Bharat Immunologicals & Biologicals Corporation Ltd.
15.68
0.00 (0.00%)
Concord Drugs Ltd.
79.03
0.00 (0.00%)
Everest Organics Ltd.
290.00
0.00 (0.00%)
Godavari Drugs Ltd.
100.00
0.00 (0.00%)
Kretto Syscon Ltd.
0.48
0.00 (0.00%)
Vasundhara Rasayans Ltd.
152.00
0.00 (0.00%)
Fortis Malar Hospitals Ltd.
47.35
-0.13 (0.27%)
Aspira Pathlab & Diagnostics FAQs
The Buying Price of Aspira Pathlab & Diagnostics share is 86.5 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Aspira Pathlab & Diagnostics stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Aspira Pathlab & Diagnostics, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Aspira Pathlab & Diagnostics shares is 37.11. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Aspira Pathlab & Diagnostics shares is 7.05. Useful to assess the stock's value relative to its book value.
To assess Aspira Pathlab & Diagnostics’s valuation compare Sector P/E, P/B which are 48.3 & -14.2 with sector averages, along with growth rates and financial metrics.
The Market Cap of Aspira Pathlab & Diagnostics is 89.03 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Aspira Pathlab & Diagnostics share price is 135.88 & 49.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Aspira Pathlab & Diagnostics belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
